• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't many studies regarding how exposure over time may affect a pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the benefits of taking them against potential risks to the fetus. Doctors don't have the information needed to make unequivocal recommendations but they can provide information regarding risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who took stimulants during the early stages of pregnancy and those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

The study of the researchers had some limitations. The most important issue was that they were unable to distinguish the effects of the medication from those of the underlying disorder. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed are due to medication use or comorbidities that cause confusion. Additionally the researchers did not study the long-term effects of offspring on their parents.

The study did find that infants whose mothers took ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not affected by the stimulant medications used during pregnancy.

Women who took stimulant adhd medication options medications during pregnancy also had a higher chance of having caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, if they are able, assist them in developing strategies for improving their coping skills that can lessen the impact of her disorder on her daily functioning and relationships.

Interactions with Medication

As more women than ever are being diagnosed with ADHD and treated with medication, the issue of whether to keep or end treatment during pregnancy is one that more and more physicians have to face. These decisions are often made without clear and authoritative evidence. Instead, doctors have to consider their own expertise in conjunction with the experiences of other doctors, and the research that has been conducted on the subject.

Particularly, the subject of potential risks for the infant can be difficult. The research that has been conducted on this topic is based on observation instead of controlled studies and a lot of the results are in conflict. The majority of studies focus on live births, which may underestimate the teratogenic impact which can cause abortions or terminations of pregnancy. The study discussed in this journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion: While some studies have shown a positive association between ADHD medications and the possibility of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slight negative effect. In each case an in-depth evaluation of the risks and benefits should be conducted.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. The loss of medication can also affect the ability to drive safely and perform work-related tasks, which are crucial aspects of everyday life for those with ADHD.

She suggests that women who are unsure about whether or not to stop medication in light of their pregnancy, consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily life, and the advantages of staying on the current treatment regimen. It can also help the woman feel supported in her struggle with her decision. Some medications can pass through the placenta. If a patient decides not to take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the drug could be passed on to her baby.

Birth Defects Risk

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the potential adverse effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies and determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD medication exposure was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The authors of the study found no link between the use of early medications and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies showing a small but significant increase in the risk of cardiac malformations among women who began taking adhd focus medication medications prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, when a lot of women stopped taking their medication.

Women who took ADHD medications in the first trimester of pregnancy were also more likely to experience caesarean sections, a low Apgar score following delivery, and a baby who needed breathing assistance during birth. The researchers of the study could not remove bias in selection since they restricted the study to women without other medical conditions that might have contributed to the findings.

Researchers hope that their research will inform physicians when they meet pregnant women. The researchers advise that, while discussing risks and benefits are important, the decision regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.

The authors caution that, although stopping the medication what is the most common adhd medication prescribed an option to think about, it isn't advised due to the high prevalence of depression and mental health issues among women who are pregnant or recently gave birth. Additionally, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties getting adhd medication uk used to life without them after the baby's arrival.

Nursing

The responsibilities of a new mother can be overwhelming. Women with ADHD may face a lot of challenges when they have to manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medications pass through breast milk in low amounts, therefore the risk for nursing infant is very low. However, the frequency of exposure to medication by the infant can differ based on dosage, how often it is taken and the time of day the medication is administered. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn isn't well understood.

Some doctors may stop taking stimulant medication during a woman’s pregnancy due to the lack of research. It's a difficult choice for the mother, who must weigh the advantages of her medication against the potential risks to the foetus. Until more information becomes available, doctors may inquire about pregnant patients if they have an history of Adhd Medication Pregnancy or if they plan to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their adhd medication and pregnancy uk medication without risk during pregnancy and breast-feeding. In response, a growing number of patients are choosing to continue their medication. They have found after consulting with their doctor that the benefits of retaining their current medication outweigh any risk.

It is essential for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss the medication they are taking with their physician and discuss the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD understand the symptoms and the underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should be a multidisciplinary effort with the GPs, obstetricians, and psychiatrists. Counselling for pregnancy should include the discussion of a treatment plan for both the mother as well as the child, as well as monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.